INBS
Income statement / Annual
Last year (2024), Intelligent Bio Solutions Inc.'s total revenue was $3.11 M,
an increase of 147.57% from the previous year.
In 2024, Intelligent Bio Solutions Inc.'s net income was -$10.16 M.
See Intelligent Bio Solutions Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$3.11 M |
$1.26 M |
$0.00 |
$1.98 M |
$188.74 K |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.69 M
|
$930.20 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$1.43 M
|
$326.67 K
|
$0.00
|
$1.98 M
|
$188.74 K
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.46
|
0.26
|
0
|
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.67 M
|
$507.42 K
|
$3.85 M
|
$3.84 M
|
$588.21 K
|
$3.18 M
|
$2.53 M
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$139.10 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$33.90 K
|
| Selling, General & Administrative Expenses |
$9.26 M
|
$8.03 M
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$173.00 K
|
| Other Expenses |
$776.50 K
|
$4.39 M
|
-$437.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.71 M
|
$8.53 M
|
$8.34 M
|
$7.20 M
|
$2.79 M
|
$6.73 M
|
$4.60 M
|
$173.00 K
|
| Cost And Expenses |
$13.40 M
|
$9.69 M
|
$8.34 M
|
$7.55 M
|
$3.05 M
|
$5.83 M
|
$4.60 M
|
$188.72 K
|
| Interest Income |
$84.82 K
|
$9.68 K
|
$14.43 K
|
$13.81 K
|
$97.00
|
$188.00
|
$0.00
|
$151.28 K
|
| Interest Expense |
$167.14 K
|
$223.53 K
|
$7.54 K
|
$1.09 M
|
$457.75 K
|
$664.84 K
|
$453.87 K
|
$0.00
|
| Depreciation & Amortization |
$1.20 M
|
$966.73 K
|
$8.34 M
|
$5.21 M
|
$2.60 M
|
$5.83 M
|
$4.60 M
|
$188.72 K
|
| EBITDA |
-$8.81 M |
-$9.47 M |
$30.83 K |
-$1.82 M |
-$561.00 K |
-$1.50 M |
-$417.00 K |
-$151.00 K |
| EBITDA Ratio |
-2.83
|
-7.54
|
0
|
-0.92
|
-2.97
|
0
|
0
|
0
|
| Operating Income Ratio |
-3.3
|
-10.02
|
0
|
-2.81
|
-14.34
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$92.24 K
|
$1.93 M
|
$2.90 K
|
-$1.71 M
|
-$336.00 K
|
-$1.56 M
|
-$453.00 K
|
-$139.00 K
|
| Income Before Tax |
-$10.19 M
|
-$10.63 M
|
-$8.33 M
|
-$8.52 M
|
-$3.16 M
|
-$7.39 M
|
-$5.06 M
|
-$312.00 K
|
| Income Before Tax Ratio |
-3.27
|
-8.46
|
0
|
-4.3
|
-16.76
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$190.70 K
|
-$27.93 K
|
$2.50 M
|
$550.26 K
|
-$57.69 K
|
-$36.39 K
|
-$167.00 K
|
| Net Income |
-$10.16 M
|
-$10.63 M
|
-$8.31 M
|
-$7.04 M
|
-$3.16 M
|
-$7.34 M
|
-$5.02 M
|
-$340.00 K
|
| Net Income Ratio |
-3.26
|
-8.46
|
0
|
-3.55
|
-16.76
|
0
|
0
|
0
|
| EPS |
-6.38 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| EPS Diluted |
-6.38 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| Weighted Average Shares Out |
$3.19 M
|
$2.01 M
|
$733.26 K
|
$520.74 K
|
$709.20 K
|
$603.96 K
|
$603.96 K
|
$603.96 K
|
| Weighted Average Shares Out Diluted |
$3.19 M
|
$2.01 M
|
$733.26 K
|
$520.74 K
|
$709.20 K
|
$603.96 K
|
$603.96 K
|
$603.96 K
|
| Link |
|
|
|
|
|
|
|
|
